To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Vol:255 Issue:3 Number:24 ISSN#:2564-2537
DOWNLOAD ESPAÑOL
Meta-Analysis
ACE Report #14720
Ace Report Cover Shoulder & Elbow

COA 2022: Retear Rates and Clinical Outcomes After Rotator Cuff Repair With vs. Without Augmentation


How to Cite

OrthoEvidence. COA 2022: Retear Rates and Clinical Outcomes After Rotator Cuff Repair With vs. Without Augmentation. ACE Report. 2022;255(3):24. Available from: https://myorthoevidence.com/AceReport/Report/14720

Study Type:Meta-analysis/Systematic Review
OE Level Evidence:1
Journal Level of Evidence:1

Rotator cuff repair with graft augmentation improves clinical and structural outcomes and decreases retear rates: a systematic review and meta-analysis

Contributing Authors:
C Imbergamo S Sequeira HP Gould

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

CONFERENCE ACE REPORTS

This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.

Synopsis

Six studies with a total of 257 shoulders were included in this systematic review and meta-analysis comparing rotator cuff repair with vs. without autograft/allograft augmentation. The outcome of interest were functional outcome scores and retear rates with a minimum follow-up period of one year. The results of this meta-analysis found that autograft/allograft augmentation resulted in a significan...

Ace Report Preview Image
CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.

LEARN MORE
For Reprints and Permissions, click here

Please Login or Join to leave comments.